Carter Bankshares Reports Strong Q4 & Full Year 2025 Earnings, Reduced NPLs, and $20M Share Repurchase
CARE sits 46% above its 52-week low of $13.605.
Summary
Carter Bankshares reported strong fourth quarter and full year 2025 financial results, with significant increases in net income and diluted EPS, alongside improved net interest margin and a notable reduction in nonperforming loans, complemented by a substantial share repurchase program.
Key Events · Earnings and Guidance · CARE
-
Strong Q4 and Full Year 2025 Financial Performance
The company reported Q4 2025 diluted EPS of $0.38, a significant increase from $0.24 in Q3 2025 and $0.36 in Q4 2024. Full year 2025 diluted EPS rose to $1.38, up from $1.06 in 2024.
-
Improved Net Interest Income and Margin
Net interest income for Q4 2025 increased to $34.6 million, up from $33.7 million in the prior quarter. Net interest margin expanded to 2.92% in Q4 2025, compared to 2.86% in Q3 2025 and 2.57% in Q4 2024.
-
Significant Reduction in Nonperforming Loans (NPLs)
Total NPLs decreased by $14.7 million to $244.0 million at December 31, 2025, with the NPLs to total portfolio loans ratio improving to 6.29% from 6.74% in the prior quarter. This was primarily driven by $14.5 million in curtailment payments on the largest nonperforming credit relationship during Q4 2025.
-
Substantial Share Repurchase Program
Carter Bankshares repurchased 1,124,690 shares of its common stock for a total cost of $20.0 million during the full year 2025, demonstrating confidence in the company's value.
Analysis · CARE · Finance
Carter Bankshares delivered robust financial results for Q4 and the full year 2025, demonstrating significant improvements in profitability and asset quality. The substantial increase in net income and diluted EPS, coupled with expanding net interest margin, indicates strong operational performance. The continued reduction in nonperforming loans, driven by significant curtailment payments on its largest credit relationship, is a positive signal regarding the management of a long-standing credit challenge. Furthermore, the company's $20.0 million share repurchase program underscores management's confidence in its valuation and commitment to shareholder returns. While the large nonperforming loan still represents a significant portion of total NPLs, its ongoing reduction is a key factor for investors to monitor.
At the time of this filing, CARE was trading at $19.92 on NASDAQ in the Finance sector, with a market capitalization of approximately $440M. The 52-week trading range was $13.61 to $21.46. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.